Keywords：专著资料, 全文在线浏览, 左半侧脑梗死导致的偏瘫失语1995.10.26
Section Index
Angiotensin-Converting Enzyme Inhibitors, February 27, 1995
Like nitroglycerin, β-blockers, and calcium channel blockers, these agents have elevated cardiovascular disease treatment to a new level. The first-generation product, captopril, appeared on the U.S. market in 1980, and the second-generation product, enalapril, was launched in 1986. Within just ten years, it became the world's most popular drug.
Captopril, also known as captopril, is a short-acting drug that does not need to be metabolized by the liver to take effect and can be dissolved under the tongue. Recently, enalapril has emerged, which is excreted unchanged by the kidneys and only needs to be taken once daily. Currently, there are no domestically produced formulations.
Indications for this drug: ① hypertension; ② heart failure; ③ coronary heart disease; ④ diabetic nephropathy.
This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.